30th Jun 2015 10:00
LONDON (Alliance News) - Circassia Pharmaceuticals PLC said Tuesday it has received acceptances for a further 4.6% of the issued share capital of Sweden-listed Aerocrine AB during the extended offer period that ended last Friday, taking its total acceptances to 97.2%.
Its GBP139 million cash offer for Aerocrine was declared unconditional earlier this month.
Shares in Circassia are trading up 0.7% at 292.75 pence Tuesday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
CIR.L